Meridian Foods: Vanity Metrics and a Silent Improvement Loop

Deficiency analysis (Clause 9.1). The clause requires determining what to monitor and measure, the methods used, when measurement occurs, who analyses and evaluates results, and when. Meridian's four KPIs are all inputs or activity: ideas submitted, pipeline size, R&D spend, patents filed. None measures whether value was realized, whether the portfolio is balanced, or whether uncertainty is managed. Worse, 'ideas submitted' rewards volume and is inflated by exactly the behaviour that produced 1,240 ideas and 9 launches.

Revised framework: four lenses.

• Value realization (lagging): percentage of revenue from products launched in the last 36 months, on a rolling three-year window; realized margin against business case at month 12; withdrawal or recall rate in the first 12 months (the two delisted products and the labelling error belong here).
• Process performance: cycle time from validated concept to launch; validation success rate; percentage of opportunities sourced from external insight; time-to-decision at each gate.
• Portfolio and uncertainty: spend balance across core, adjacent and transformational; number of experiments concluded with documented learning; proportion of projects stopped against kill criteria, which is a healthy signal, not a failure.
• Capability and culture: competence coverage for key roles; survey measures of psychological safety and management responsiveness; active external collaborations.

Method notes. Define each indicator's formula, data source (finance, PLM, HR system), frequency and owner, and record it. 'R&D spend' is unambiguous; 'innovation rate' is not. Present at least two data points per indicator so trends, not snapshots, are discussed.

Expected audit challenge. 'Show me how these results are analysed and evaluated, not just reported.' A dashboard without interpretation fails the clause.

Internal audit (Clause 9.2). The programme must be planned considering the importance of processes, changes affecting the organization and previous audit results; it must cover all requirements of the standard, with objective and impartial auditors.

Deficiencies and fixes:

• Coverage: the 2026 plan omits the innovation clauses. Add Clause 8 (process, IP, portfolio) and Clause 9 in the first half of 2026; these are the highest-risk areas given the launch failures.
• Impartiality: the innovation coordinator cannot audit work she owns. Pair an ISO 9001 auditor from another business unit with a technically competent subject-matter expert.
• Competence: existing auditors need training on innovation requirements and on auditing uncertainty and portfolio decisions, which are judgement-based rather than checklist-based.
• Criteria: audit against the standard and against Meridian's own defined process and criteria, or findings will be generic.
• Findings discipline: 18 months with no corrective action suggests findings are logged as observations and never graded. Grade them, assign owners, set dates.

Management review (Clause 9.3). The clause specifies inputs (status of actions, changes in issues, performance and trends, audit results, nonconformities and corrective actions, interested-party feedback, risks and opportunities, improvement opportunities) and outputs (decisions on improvement opportunities and resource needs). Two hours of slides with minutes saying 'discussed innovation' evidences neither.

Fix: a standing agenda mapped to the clause inputs, a pre-circulated data pack with trends, a decision log with owner and date, and a status-of-actions item opening the next review. Each business unit presents against the same indicators so the group can compare. The test is whether the review changes anything.

Requirement (Clause 10). On a nonconformity the organization must react (contain and correct), evaluate the need for action to eliminate the cause, implement it, review its effectiveness, update risks and opportunities, and change the management system if necessary. Documented information of the nonconformity, actions taken and results is required. Continual improvement of the suitability, adequacy and effectiveness of the system is expected.

Missed objectives with no corrective action is itself a nonconformity. Either the objectives were not monitored (Clauses 6 and 9) or the results were not acted on (Clause 10). Treat both, not just the symptom.

Handling the labelling error.

1. Contain: withdraw or relabel affected batches; verify other SKUs and other business units using the same artwork workflow.
2. Root cause: the error is unlikely to be an individual mistake. Ask whether the deployment stage has a defined regulatory and labelling validation step, whether the artwork change entered through the innovation process or bypassed it, and whether the same design tool is used group-wide.
3. Corrective action: make the labelling and claims check mandatory at the validation gate with a named accountable role; update the risk register; test whether the two delisted products share a cause, such as no post-launch value review at month six.
4. Effectiveness: review at the next management review using counts of labelling changes checked, near-misses recorded, and zero repeats.
5. Extend: check whether allergen and nutrition claims sit in the same gap.

Audit test. The auditor will ask for one closed corrective action from the last 12 months. Meridian has none, which is a stronger negative signal than the original error.